Turning high-throughput structural biology into predictive inhibitor design by Saar, KL, McCorkindale, W, Fearon, D, Boby, M, Barr, H, Ben-Shmuel, A, London, N, von Delft, F, Chodera, JD, Lee, AA, Koekemoer, L, Krojer, T, Fairhead, M, MacLean, EM, Thompson, A, Smilova, MD, Wright, N, von Delft, A, Gileadi, C, Schofield, CJ, Salah, E, Malla, TR, Tumber, A, John, T, Vakonakis, I, Kantsadi, AL, Zitzmann, N, Brun, J, Kiappes, JL, Hill, M, Witt, KD, Alonzi, DS, Makower, LL, Giroud, C, Bennett, J, Fedorov, O, Morris, GM, Ferla, M, Carbery, A, Cattermole, E, Taylor, JC, Brewitz, L

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors by Boby, ML, Fearon, D, Ferla, M, Filep, M, Koekemoer, L, Robinson, MC, Chodera, JD, Lee, AA, London, N, von Delft, A, von Delft, F, Achdout, H, Aimon, A, Alonzi, DS, Arbon, R, Aschenbrenner, JC, Balcomb, BH, Bar-David, E, Barr, H, Ben-Shmuel, A, Bennett, J, Bilenko, VA, Borden, B, Boulet, P, Bowman, GR, Brewitz, L, Brun, J, Bvnbs, S, Calmiano, M, Carbery, A, Carney, DW, Cattermole, E, Chang, E, Chernyshenko, E, Clyde, A, Coffland, JE, Cohen, G, Cole, JC, Contini, A, Cox, L, Croll, TI, Cvitkovic, M, De Jonghe, S, Dias, A, Donckers, K, Dotson, DL, Douangamath, A, Duberstein, S, Dudgeon, T, Fairhead, M, Taylor, JC, Zitzmann, N